









Liverly - Mixed Reality Liver Disease Therapeutics
Mixed Reality Spatial Therapeutics
Ni Design
Liverly is one of the first mixed reality therapeutic tools in the world designed for Nonalcoholic Fatty Liver Disease (NAFLD), a chronic condition affecting 32% of the global population with no pharmaceutical treatments available. Liverly offers a unique, non-invasive experience that harnesses advanced research in circadian rhythm and autophagy to support liver health. Through interactive, personalized visualizations, users engage with scientifically-backed strategies for proactive liver wellness. Liverly’s spatial therapeutics approach empowers users to take charge of their liver health in a groundbreaking way.
Client / ManufacturerDesign
Ni Design
Los Angeles, CA, USZehui Ni
Los Angeles, CA, USDate of Launch
2024
Development Time
up to 12 Month
Target Regions
Australia / Oceania, Europe, North America
Target Groups
Consumers / Users